Learning Session II
May 22, 2012
- Agenda (doc)
- Welcome and Overview - Dennis McCarty, PhD
- Pharmacotherapies for Alcohol Use Disorders - Marc Fishman, MD
- Clinical Perspectives: Buprenorphine- Robert Schwartz, MD
- Staff Resistance - Kim Johnson, MBA
- Business Case vs Cost Effectiveness - Jay Ford, PhD